Identification of gene expression profiles in acute lymphoblastic leukemia cells that discriminate intracellular thioguanine nucleotide accumulation in ALL cells after in vivo treatment with mercaptopurine.

被引：0

作者：

Zaza, G ^{[1
]}

Cheok, M ^{[1
]}

Yang, WJ ^{[1
]}

Pei, DQ ^{[1
]}

Cheng, C ^{[1
]}

Pui, CH ^{[1
]}

Relling, MV ^{[1
]}

Evans, WE ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA

来源：

BLOOD | 2004年 / 104卷 / 11期

关键词：

D O I：

10.1182/blood.V104.11.453.453

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

453

引用

页码：132A / 132A

页数：1

共 23 条

[11] Connexin expression in human acute myeloid leukemia cells: Identification of patient subsets based on protein and global gene expression profiles
Reikvam, Hakon
Ryningen, Anita
Saeterdal, Lars Rune
Nepstad, Ina
Foss, Brynjar
Bruserud, Oystein
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (03) : 645 - 652
[12] Downregulation of Interleukin-1 gene expression after application of the antiemetic agent ondansetron to acute lymphoblastic leukemia cells in vitro
Prada, J.
ONKOLOGIE, 2010, 33 : 237 - 237
[13] Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells (vol 34, pg 85, 2003)
Cheok, MH
Yang, W
Pui, CH
Downing, JR
Cheng, C
Naeve, CW
Relling, MV
Evans, WE
NATURE GENETICS, 2003, 34 (02) : 231 - 231
[14] Differential gene expression in leukemic cells from bone marrow (BM) and peripheral blood (PB) of pediatric patients with acute lymphoblastic leukemia (ALL).
Rhein, P
Scheid, S
Hagemeier, C
Seeger, K
Kirschner, R
Schrappe, M
Spang, R
Ludwig, WD
Karawajew, L
BLOOD, 2004, 104 (11) : 523A - 523A
[15] Identification of Gene Expression Signatures in Leukemia Stem Cells and Minimal Residual Disease Following Treatment of Adverse Risk Acute Myeloid Leukemia
Issa, Ghayas C.
Benton, Christopher B.
Mohanty, Vakul
Shen, Yifei
Alaniz, Zoe
Wang, Feng
Futreal, P. Andrew
Wang, Wei
Jorgensen, Jeffrey L.
Navin, Nicholas
Konopleva, Marina Y.
Chen, Ken
Andreeff, Michael
BLOOD, 2019, 134
[16] Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia
Gunnar Cario
Andrea Fetz
Christian Bretscher
Anja Möricke
Andre Schrauder
Martin Stanulla
Martin Schrappe
Annals of Hematology, 2008, 87
[17] Initial leukemic gene expression profiles of patients with poor in vivo prednisone response are similar to those of blasts persisting under prednisone treatment in childhood acute lymphoblastic leukemia
Cario, Gunnar
Fetz, Andrea
Bretscher, Christian
Moericke, Anja
Schrauder, Andre
Stanulla, Martin
Schrappe, Martin
ANNALS OF HEMATOLOGY, 2008, 87 (09) : 709 - 716
[18] NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A FlowCytometric Marker for the Rapid Identification of KMT2A Gene Rearrangements
Bisegna, Maria Laura
Peragine, Nadia
Elia, Loredana
Matarazzo, Mabel
Milani, Maria Laura
Intoppa, Stefania
Di Trani, Mariangela
Malfona, Francesco
Martelli, Maurizio
De Propris, Maria Stefania
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
[19] Gene expression profiles of leukemic cells isolated from patients with chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia (PH+ ALL) receiving the Abl-kinase inhibitor STI571.
von Bubnoff, N
Schneller, F
Peschel, C
Duyster, J
BLOOD, 2001, 98 (11) : 567A - 567A
[20] Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells
Reikvam, Hakon
Hovland, Randi
Forthun, Rakel Brendsdal
Erdal, Sigrid
Gjertsen, Bjorn Tore
Fredly, Hanne
Bruserud, Oystein
BMC CANCER, 2017, 17

← 1 2 3 →